Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Thyroid Cancer
Intervention: Other: Decision aid exposure
Sponsors: University Health Network, Toronto; Ontario Ministry of Health and Long Term Care; Canadian Institutes of Health Research (CIHR)
Recruiting - verified January 2010
Condition: Thyroid Cancer
Intervention:
Sponsor: National Cancer Institute, Naples
Recruiting - verified February 2010
Conditions: Parathyroid Adenoma; Thyroid Adenoma
Intervention:
Sponsor: Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified March 2010
Condition: Head and Neck Neoplasms
Interventions: Drug: Pemetrexed; Drug: Cetuximab; Drug: Cisplatin
Sponsor: Eli Lilly and Company
Not yet recruiting - verified February 2010
Condition: Thyroid Cancer
Intervention: Procedure: Fine needle aspiration
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified July 2009
Conditions: Stomach Cancer; Colon Cancer; Thyroid Cancer; Breast Cancer
Intervention: Behavioral: Brochure of Secondary Cancer Screening
Sponsor: National Cancer Center, Korea
Active, not recruiting - verified September 2009
Conditions: Breast Cancer; Hypercalcemia of Malignancy; Colon Cancer; Endocrine Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Metastatic Cancer; Multiple Myeloma; Parathyroid Neoplasms; Renal Cancer; Thyroid Cancer; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Non-small Cell Lung Cancer
Intervention: Drug: denosumab
Sponsor: Amgen
Recruiting - verified March 2010
Condition: Solid Tumors
Intervention: Drug: AG-013736
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Thyroid Cancer
Interventions: Drug: XL184; Drug: Placebo
Sponsor: Exelixis
Recruiting - verified March 2010
Condition: Carcinoma, Renal Cell
Intervention: Drug: Sunitinib Malate (SU011248)
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Head and Neck Cancer
Interventions: Drug: pazopanib hydrochloride; Other: laboratory biomarker analysis
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified December 2008
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: combretastatin A-4 phosphate (CA4P); Drug: paclitaxel; Drug: carboplatin
Sponsor: OXiGENE
Active, not recruiting - verified February 2010
Conditions: Hypothyroidism; Brain Tumor
Interventions: Drug: Levothyroxine; Drug: Liothyronine
Sponsor: M.D. Anderson Cancer Center
Active, not recruiting - verified February 2010
Condition: Thyroid Neoplasms
Intervention: Drug: AG-013736
Sponsor: Pfizer
Active, not recruiting - verified March 2010
Conditions: Solid Tumor; Thyroid Cancer
Interventions: Drug: Capecitabine (Xeloda); Drug: DTIC-Dome (Dacarbazine); Drug: Gleevec (Imatinib Mesylate)
Sponsors: M.D. Anderson Cancer Center; Novartis Pharmaceuticals
Active, not recruiting - verified February 2010
Conditions: Thyroid Cancer; Thyroid Disease
Intervention:
Sponsor: National Cancer Institute (NCI)
Active, not recruiting - verified February 2010
Condition: Thyroid Cancer
Intervention:
Sponsor: National Cancer Institute (NCI)
Completed - verified March 2009
Conditions: Breast Cancer; Fatigue; Hypothyroidism
Interventions: Other: physiologic testing; Procedure: fatigue assessment and management; Procedure: management of therapy complications
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)
Recruiting - verified November 2009
Condition: Thyroid Nodules
Intervention: Other: No intervention. Applying gene profiling on needle aspirates
Sponsor: Herlev Hospital
Enrolling by invitation - verified October 2007
Condition: Head and Neck Cancer
Intervention: Drug: sorafenib tosylate
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Cancer
Interventions: Procedure: Acupuncture and questionnaires; Procedure: placebo acupuncture
Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting - verified February 2010
Condition: Thyroid Cancer
Intervention: Drug: AMG 706
Sponsor: Amgen
Active, not recruiting - verified February 2010
Condition: Head and Neck Cancer
Intervention: Drug: bortezomib
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Suspended - verified June 2009
Condition: Cancer
Interventions: Drug: isolated perfusion; Drug: melphalan
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: Head and Neck Cancer
Interventions: Biological: filgrastim; Biological: pegfilgrastim; Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: fosbretabulin disodium; Radiation: radiation therapy
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Completed - verified March 2010
Condition: Head and Neck Cancer
Intervention: Drug: fosbretabulin disodium
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Completed - verified March 2010
Conditions: Head and Neck Cancer; Lung Cancer
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: paclitaxel; Radiation: radiation therapy
Sponsors: Fox Chase Cancer Center; National Cancer Institute (NCI)
Completed - verified February 2010
Condition: Head and Neck Cancer
Interventions: Drug: paclitaxel; Drug: semaxanib
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Completed - verified February 2010
All Categories ... by Medical Condition » ... Cancers » ... Thyroid Cancer 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
